Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Xiaobo Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4995-1574; OpenAlex author ID A5100410390. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 4

  1. An immunogenic cell death-related gene expression signature in predicting prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12864-024-10106-7↗
  2. [Retracted] MicroRNA‑153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2022.8444↗
  3. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells. Co-author DOI 10.1371/journal.pone.0118814↗
  4. MicroRNA-153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2015.4051↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Honghong Pei · 3 shared papers, 2015–2023 · strength 0.34
  2. Zhengliang Zhang · 3 shared papers, 2015–2023 · strength 0.34
  3. Zhenghai Bai · 3 shared papers, 2015–2023 · strength 0.34
  4. Jing Cao · 1 shared paper, 2024 · strength 0.28
  5. Ling Bai · 1 shared paper, 2015 · strength 0.06
  6. Fei Miao · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.